Welcome to
RBP World!
Drugs target to LGALS3
| Drug name | Drug type | Disease/phenotype | Mechanism of action(MoA) | Phase | Status | Source |
|---|---|---|---|---|---|---|
| BELAPECTIN | Unknown | non-alcoholic steatohepatitis | Galectin-3 inhibitor | 2.0 | Completed | ClinicalTrials |
| OLITIGALTIN | Small molecule | idiopathic pulmonary fibrosis | Galectin-3 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| BELAPECTIN | Unknown | non-alcoholic fatty liver disease | Galectin-3 inhibitor | 1.0 | Completed | ClinicalTrials |
| BELAPECTIN | Unknown | psoriasis | Galectin-3 inhibitor | 2.0 | Completed | ClinicalTrials |
| OLITIGALTIN | Small molecule | idiopathic pulmonary fibrosis | Galectin-3 inhibitor | 1.0 | Completed | ClinicalTrials |
| OLITIGALTIN | Small molecule | COVID-19 | Galectin-3 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| BELAPECTIN | Unknown | portal hypertension | Galectin-3 inhibitor | 2.0 | Completed | ClinicalTrials |
| DAVANAT | Unknown | colorectal carcinoma | Galectin-3 inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| BELAPECTIN | Unknown | metastatic melanoma | Galectin-3 inhibitor | 1.0 | Completed | ClinicalTrials |
| BELAPECTIN | Unknown | liver disease | Galectin-3 inhibitor | 1.0 | Completed | ClinicalTrials |
| DAVANAT | Unknown | metastatic melanoma | Galectin-3 inhibitor | 1.0 | Terminated | ClinicalTrials |
| BELAPECTIN | Unknown | melanoma | Galectin-3 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |